Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.34 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.34 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.34 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 3/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL296310 | 1.00 | ALDH1A1 (0.47) | ALDH1A1LMNATSHRMAPTABCC4 | |
| SCHEMBL6037419 | 1.00 | ALDH1A1 (0.47) | ALDH1A1LMNATSHRMAPTABCC4 | |
| SCHEMBL6037317 | 1.00 | ALDH1A1 (0.47) | ALDH1A1LMNATSHRMAPTABCC4 | |
| SCHEMBL6037311 | 1.00 | ALDH1A1 (0.47) | ALDH1A1LMNATSHRMAPTABCC4 | |
| SCHEMBL6064240 | 1.00 | ALDH1A1 (0.47) | ALDH1A1LMNATSHRMAPTABCC4 | |
| SCHEMBL31351367 | 1.00 | ALDH1A1 (0.47) | ALDH1A1LMNATSHRMAPTABCC4 | |
| SCHEMBL6064484 | 1.00 | ALDH1A1 (0.47) | ALDH1A1LMNATSHRMAPTABCC4 | |
| SCHEMBL296166 | 0.98 | ALDH1A1 (0.44) | ALDH1A1LMNATSHRMAPTABCC4 | |
| SCHEMBL466716 | 0.91 | ALDH1A1 (0.41) | ALDH1A1LMNATSHR | |
| SCHEMBL9155232 | 0.84 | TSHR (0.46) | ALDH1A1LMNATSHRMAPTABCC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8101697-B2 | Multi-functionalized high-trans elastomeric polymers | BRIDGESTONE CORPORATION (JP) | 2012-01-24 | — | — | US | claimed |
| US-20060173145-A1 | Multi-functionalized high-trans elastomeric polymers | BRIDGESTONE CORPORATION (JP) | 2006-08-03 | — | — | US | claimed |
| EP-3612303-B1 | METHOD FOR MAKING WATER-ABSORBING POLYMER PARTICLES HAVING AREAS WITH INORGANIC SOLID PARTICLES AND AREAS SUBSTANTIALLY FREE OF INORGANIC SOLID PARTICLES | PROCTER & GAMBLE (US) | 2026-04-29 | — | — | EP | disclosed |
| EP-3612304-B1 | METHOD FOR MAKING WATER-ABSORBING POLYMER PARTICLES | PROCTER & GAMBLE (US) | 2026-04-22 | — | — | EP | disclosed |
| EP-4628109-A2 | METHOD FOR MAKING WATER-ABSORBING POLYMER PARTICLES | The Procter & Gamble Company (US) | 2025-10-08 | — | — | EP | disclosed |
| EP-3391961-B1 | METHOF OF OBTAINING AGGLOMERATED SUPERABSORBENT POLYMER PARTICLES HAVING A SPECIFIC SIZE RATIO | PROCTER & GAMBLE (US) | 2025-05-21 | — | — | EP | disclosed |
| WO-2025023143-A1 | GLASS CLOTH TREATMENT LIQUID AND SURFACE TREATED GLASS CLOTH | 信越化学工業株式会社 | 2025-01-30 | — | — | WO | disclosed |
| EP-3391960-B1 | SUPERABSORBENT POLYMER PARTICLES COMPRISING ONE, OR MORE THAN ONE AREA(S) WITH CLAY PLATELETS AND AT LEAST TWO DISTINCT, NON-ADJACENT AREAS WITH NO CLAY PLATELETS | PROCTER & GAMBLE (US) | 2023-11-22 | — | — | EP | disclosed |
| US-11746237-B2 | Organosiloxane compound and surface treatment agent | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-09-05 | — | — | US | disclosed |
| EP-4147774-A1 | METHOD FOR MAKING WATER-ABSORBING POLYMER PARTICLES HAVING AREAS WITH INORGANIC SOLID PARTICLES AND AREAS SUBSTANTIALLY FREE OF INORGANIC SOLID PARTICLES | The Procter & Gamble Company (US) | 2023-03-15 | — | — | EP | disclosed |
| CN-110545909-B | Method for producing water-absorbing polymer particles | 宝洁公司 | 2023-02-03 | — | — | CN | disclosed |
| US-8968458-B2 | Composition for resist underlayer film and process for producing same | JSR CORPORATION (JP) | 2015-03-03 | — | — | US | disclosed |
| US-8808446-B2 | Composition for resist underlayer film and process for producing same | JSR CORPORATION (JP) | 2014-08-19 | — | — | US | disclosed |
| US-8101697-B2 | Multi-functionalized high-trans elastomeric polymers | BRIDGESTONE CORPORATION (JP) | 2012-01-24 | — | — | US | disclosed |
| US-20100151384-A1 | COMPOSITION FOR RESIST UNDERLAYER FILM AND PROCESS FOR PRODUCING SAME | JSR CORPORATION (JP) | 2010-06-17 | — | — | US | disclosed |
| US-20090050020-A1 | COMPOSITION FOR RESIST UNDERLAYER FILM AND PROCESS FOR PRODUCING SAME | JSR CORPORATION (JP) | 2009-02-26 | — | — | US | disclosed |
| EP-1855159-A1 | COMPOSITION FOR UNDERLAYER FILM OF RESIST AND PROCESS FOR PRODUCING THE SAME | JSR Corporation (JP) | 2007-11-14 | — | — | EP | disclosed |
| US-20060173145-A1 | Multi-functionalized high-trans elastomeric polymers | BRIDGESTONE CORPORATION (JP) | 2006-08-03 | — | — | US | disclosed |
| US-7015292-B2 | Silicon-containing olefin copolymer, crosslinkable rubber composition thereof, and use thereof | MITSUI CHEMICALS, INC. (JP) | 2006-03-21 | — | — | US | disclosed |
| US-20050038214-A1 | Silicon-containing olefin copolymer, crosslinkable rubber composition thereof, and use thereof | MITSUI CHEMICALS, INC. (JP) | 2005-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060173145-A1 | Multi-functionalized high-trans elastomeric polymers | VCL, PUF60, JMJD6 | ALDH1A1 3595/4885LMNA 1616/4885TSHR 4359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.